Brief Title
Prognostic Factors in Periampullary Tumors and Cysts
Official Title
Prognostic Factors, Operative Care and Short and Long Term Outcomes for Cysts and Tumors in Pancreas and the Periampullary Region
Brief Summary
The project aims at analysing prognostic and predictive factors involved in diagnostics and
surgical treatment of cysts and tumors in the pancreas and periampullary region using both
clinical data and blood and tissue samples for biomarker development and validation.
Detailed Description
From november 2021 an onward, study participants will be prospectively enrolled within the
observational study. Before that, study participants are retrospectively enrolled. The study
has a broad perspective including studies on clinical outcomes and prognostics based on
patient and tumor characteristics.
Study Type
Observational [Patient Registry]
Primary Outcome
Overall survival
Secondary Outcome
Complications
Condition
Pancreas Cancer
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
500
Start Date
September 1, 2021
Completion Date
January 1, 2040
Primary Completion Date
January 1, 2035
Eligibility Criteria
Inclusion Criteria:
- Recommended surgery for tumor or cyst in the pancreas or periampullary region
- Information avalible in electronic journal files
- Informed consent (or deceased for retrospective part of the study)
Exclusion Criteria:
- No informed consent (and still alive at study initiation)
Gender
All
Ages
18 Years - N/A
Accepts Healthy Volunteers
No
Contacts
Oskar Franklin, MD/PhD, +4690785000, [email protected]
Location Countries
Sweden
Location Countries
Sweden
Administrative Informations
NCT ID
NCT05155878
Organization ID
UmU-parpanc
Responsible Party
Principal Investigator
Study Sponsor
Umeå University
Study Sponsor
Oskar Franklin, MD/PhD, Principal Investigator, Umeå University Hospital
Verification Date
December 2021